the High Authority for Health justifies its negative opinion for the reimbursement of a potential treatment
At the end of October, the HAS refused “early” access to Biogen’s Qalsody, indicated in a rare genetic form of the pathology, which aroused the anger of patients. On October 25, the opinion of the High Authority for Health (HAS) had the effect of a cold shower for patients suffering from a rare form of … Read more